Luca Posa
banner
dr-lupo.bsky.social
Luca Posa
@dr-lupo.bsky.social
Behavioral neuroscientist 🧠 Postdoc @weillcornell.bsky.social #PharmDPhD #pain #emotion #GPCRs #opioids 🔬 #DiversitySTEM #firstgen. He/him🌈 Traveller
Pinned
Excited to share our new preprint here! A photocromic morphinian-azobenzene, efficacy switch and peripherally restricted analgesic. Great collaboration between Levitz, @dirktrauner.bsky.social @gati.bsky.social and Seva Katritch's labs! 👇🏻👇🏻 www.biorxiv.org/content/10.1...
Great structure work about MOR binding states from the Cornelius Gati lab! Congrats to all the authors, particularly Saif Khan. Looking forward!
November 5, 2025 at 11:08 PM
So cool! 👇🏼👇🏼👇🏼A β-arrestin-2-biased modulator of neurotensin receptor 1 relieves acute and chronic pain by blocking neural sensitization while also reducing opioid abuse risk without affecting motor or cognitive functions

www.cell.com/cell/abstrac...
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain
SBI-810, an arrestin-biased allosteric modulator of neurotensin receptor 1, can effectively alleviate acute and chronic pain in rodent models via peripheral and central modulation and can also mitigat...
www.cell.com
August 10, 2025 at 2:14 AM
A bit late but definitely proud of my first talk @INRC2025!
July 25, 2025 at 2:04 AM
My first time at #usasp2025. Great science, new and old friends. First talk in a symposium at an international conference. Thank you to my co-speakers @stefpuig.bsky.social and Ream Al-Asani
May 3, 2025 at 1:40 AM
Reposted by Luca Posa
our NIH HEAL initiative funded biomarkers study now out @jama.com JAMA Neurology

open access, open data and code

w/ @drsmschabrun.bsky.social

jamanetwork.com/journals/jam...
Predicting Individual Pain Sensitivity Using a Novel Cortical Biomarker Signature
This cohort study analyzes electroencephalography data from healthy participants to analyze and validate a cortical biomarker signature for pain, which comprised the measures sensorimotor peak alpha f...
jamanetwork.com
January 27, 2025 at 4:43 PM
Reposted by Luca Posa
Excited to present our lab's new work on GPCR antagonism: Contrary to popular belief, we propose that inverse agonists can bind to and act via GPCR:G protein complexes. We show this at KOR, through cellular assays, radioligand binding and cryoEM studies. A thread. 💊 🧪 www.nature.com/articles/s41...
January 7, 2025 at 4:09 PM
Excited to share our new preprint here! A photocromic morphinian-azobenzene, efficacy switch and peripherally restricted analgesic. Great collaboration between Levitz, @dirktrauner.bsky.social @gati.bsky.social and Seva Katritch's labs! 👇🏻👇🏻 www.biorxiv.org/content/10.1...
December 23, 2024 at 2:02 PM